An Open Label Extension Study of Phase 3 Trial of Duloxetine in Patients With Osteoarthritis and Knee Pain
Phase of Trial: Phase III
Latest Information Update: 03 May 2017
At a glance
- Drugs Duloxetine (Primary)
- Indications Osteoarthritis; Pain
- Focus Adverse reactions
- Sponsors Eli Lilly
- 04 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Jun 2015 Planned primary completion date changed from 1 Mar 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.